NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo announced a quarterly dividend on Thursday, February 14th. Shareholders of record on Friday, March 1st will be paid a dividend of $0.19 per share on Tuesday, March 19th. This represents a $0.76 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date of this dividend is Thursday, February 28th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) released its quarterly earnings results on Thursday, August, 9th. The company reported $1.22 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.21 by $0.01. The company had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.23 billion. Perrigo had a return on equity of 11.32% and a net margin of 2.54%. Perrigo's revenue was down 4.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.22 EPS. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Wednesday, February 27th 2019. View Earnings Estimates for Perrigo.

13 brokerages have issued 12-month price targets for Perrigo's stock. Their forecasts range from $46.00 to $110.00. On average, they expect Perrigo's stock price to reach $77.3571 in the next twelve months. This suggests a possible upside of 58.0% from the stock's current price. View Analyst Price Targets for Perrigo.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 10 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

Media stories about PRGO stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Perrigo earned a news impact score of 1.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future.

Perrigo saw a decrease in short interest in December. As of December 31st, there was short interest totalling 5,474,515 shares, a decrease of 37.7% from the December 14th total of 8,791,586 shares. Based on an average daily volume of 3,537,573 shares, the days-to-cover ratio is currently 1.5 days. Approximately 4.0% of the company's shares are short sold. View Perrigo's Current Options Chain.

Some companies that are related to Perrigo include Shiseido (SSDOY), Teva Pharmaceutical Industries (TEVA), UCB (UCBJF), BioMarin Pharmaceutical (BMRN), Mylan (MYL), Ono Pharmaceutical (OPHLF), Merck KGaA (MKGAF), GRIFOLS S A/S (GRFS), Genmab A/S (GNMSF), Sarepta Therapeutics (SRPT), Bausch Health Companies (BHC), Alnylam Pharmaceuticals (ALNY), Ionis Pharmaceuticals (IONS), Beigene (BGNE) and Jazz Pharmaceuticals (JAZZ).

Perrigo's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.23%), Clal Insurance Enterprises Holdings Ltd (1.74%), Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.29%), Geode Capital Management LLC (1.24%), Dimensional Fund Advisors LP (1.07%) and Northern Trust Corp (1.06%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Iridian Asset Management LLC CT, Parnassus Investments CA, Manning & Napier Group LLC, Mackenzie Financial Corp, Menora Mivtachim Holdings LTD., Canada Pension Plan Investment Board and Thrivent Financial for Lutherans. View Insider Buying and Selling for Perrigo.

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Dimensional Fund Advisors LP, Clal Insurance Enterprises Holdings Ltd, First Trust Advisors LP, Geode Capital Management LLC, TD Asset Management Inc., BlackRock Inc. and Macquarie Group Ltd.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $48.95.

Perrigo has a market capitalization of $6.65 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

The official website for Perrigo is http://www.perrigo.com.

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]